INDOCO REMEDIES

InCred Healthcare PMS achieved top rankings in Nov 2024, with Focused Healthcare PMS leading for the year. The fund's strategy focuses on cash flows and cash flow valuation multiples, investing in 15-20 stocks across healthcare segments. It emphasizes sustainable profitability, with overweight positions in hospitals, diagnostics, and API, expecting continued earnings growth. Key industry triggers include US Bio Secure Act developments and hospital sector consolidation.

Indoco Remedies receives final USFDA approval for Cetirizine Hydrochloride Tablets, 10 mg, used for hay fever and allergy relief.

Indoco Remedies receives USFDA approval for generic Cetirizine tablets, equivalent to Zyrtec Allergy Tablets, to be manufactured in Goa, India.